Atomoxetine hydrochloride

Ref. IN-DA00500D

Produktinformation

• Name: Atomoxetine hydrochloride
• Synonyme: [u'139603, LY', u'atomoxetine', u'Atomoxetine HCl', u'HCl, Atomoxetine', u'Hydrochloride, Atomoxetine', u'LY 139603', u'N-methyl-gamma-(2-methylphenoxy)benzenepropanamine hydrochloride', u'Strattera', u'tomoxetine', u'Tomoxetine Hydrochloride, (+)-isomer - T351671', u'tomoxetine hydrochloride, (+-)-isomer', u'tomoxetine hydrochloride, (-)-isomer', u'Atomoxetine HCL', u'82248-59-7', u'Strattera', u'TOMOXETINE HYDROCHLORIDE', u'(R)-Tomoxetine hydrochloride', u'(R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine hydrochloride', u'LY 139603', u'(R)-(-)-Tomoxetine hydrochloride', u'UNII-57WVB6I2W0', u'Atomoxetine hydrochloride [USAN]', u'LY-139603', u'57WVB6I2W0', u'CHEBI:331697', u'MFCD06410992', u'(-)-N-Methyl-3-phenyl-3-(o-tolyloxy)propylamine hydrochloride', u'C17H21NO.HCl', u'DSSTox_CID_24266', u'DSSTox_RID_80136', u'DSSTox_GSID_44266', u'(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine hydrochloride', u'Benzenepropanamine, N-methyl-gamma-(2-methylphenoxy)-, hydrochloride, (-)-', u'SMR000469177', u'CAS-82248-59-7', u'Tomoxetine HCl', u'(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochloride', u'Atomoxetine, HCl', u'Strattera (TN)', u'tomoxetine hydrochloride, (-)-isomer', u'AC1L1HTF', u'NCGC00016056-02', u'AK-72912', u'CHEMBL1702', u'MLS001401377', u'MLS002153176', u'SCHEMBL122111', u'(-)-N-methyl-3-phenyl-3-(o-tolyloxy)-propylamine hydrochloride', u'DTXSID2044266', u'LUCXVPAZUDVVBT-UNTBIKODSA-N', u'HMS3677C05', u'(R)-Tomoxetine hydrochloride, solid', u'Tox21_110292', u'(R)-ATOMOXETINE HYDROCHLORIDE', u'Atomoxetine hydrochloride (JAN/USP)', u'LY-139602 [(+)-isomer]', u's3175', u'AKOS015920150', u'Tox21_110292_1', u'AB25136', u'API0001557', u'CCG-100874', u'CS-1085', u'KS-1223', u'NC00124', u'SB17442', u'NCGC00025345-02', u'AN-11139', u'AT-20429', u'BR-72912', u'CPD000469177', u'HY-17385', u'K464', u'LY139603', u'SAM001246626', u'SC-17967', u'AB0014234', u'LS-177676', u'LY-135252', u'AM20060733', u'FT-0655350', u'ST24020766', u'SW197504-3', u'D02574', u'M-1314', u'248T597', u'SR-01000597779', u'SR-01000763397', u'SR-01000597779-1', u'SR-01000763397-3', u'F0001-2408', u'Atomoxetine Hydrochloride 1.0 mg/ml in Methanol (as free base)', u'(R)-N-Methyl-?-(2-methylphenoxy)-benzenepropanamine hydrochloride', u'(R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropylamine Hydrochloride', u'(R)-N-METHYL-3-PHENYL-3-(O-TOLYLOXY)PROPAN-1-AMINE HCL', u'(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine hydrochloride', u'(R)-(-)-N-methyl-3-(2-methylphenoxy)-3-phenylpropylamine hydrochloride', u'(R)-N-Methyl-gamma-(2-methyl-phenoxy)benzenepropanamine hydrochloride', u'(r)-n-methyl-gamma-(2-methylphenoxy)-benzenepropanamine hydrochloride', u'Atomoxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard', u'METHYL-((R)-3-PHENYL-3-O-TOLYLOXY-PROPYL)-AMINE HYDROCHLORIDE', u'Atomoxetine for impurity A identification, European Pharmacopoeia (EP) Reference Standard', u'Atomoxetine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material', u'Atomoxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard']
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 291.8157
• Formel: C₁₇H₂₁ClNO
• Reinheit: 99%
• Farbe/Form: Solid
• InChl: InChI=1S/C17H21NO.ClH/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15;/h3-11,17-18H,12-13H2,1-2H3;1H/t17-;/m1./s1
• InChI Key: LUCXVPAZUDVVBT-UNTBIKODSA-N